Kyle N. Campbell, PharmD, MS
Vice President, Healthcare Policy and Quality Measurement
Dr. Campbell oversees national projects related to quality measure development, healthcare policy and evaluation, and medication safety. His experience includes developing and maintaining clinical quality measures for use in Centers for Medicare & Medicaid Services (CMS) quality programs, advising on national policy related to measure development, designing and implementing quality improvement interventions, and overseeing research studies related to medication safety. He has led and participated in several large contracts with CMS that resulted in National Quality Forum endorsement of multiple performance measures related to medication management, adverse drug events, and behavioral health. Dr. Campbell currently directs Measure & Instrument Development and Support (MIDS) tasks related to the National Impact Assessment of CMS Quality and Efficiency Measures. In this role, he also oversaw the development of the CMS Quality Measure Development Plan (MDP) and accompanying MDP Annual Reports, as well as the development of the Quality Measure Index (QMI), a novel tool to assess quality measures. He has been invited to speak at numerous national conferences on quality measure development and has served on national expert panels related to both measure development and medication safety. Dr. Campbell earned his pharmacy degree from the University of Florida and his Master’s degree from the University of South Florida.
Under Dr. Campbell’s supervision, the following team leads manage staff activities for contracts with CMS and other clients:
Kendra Hanley, MS, BA
Ms. Hanley is a nationally recognized expert with 15 years of experience in the development and specification of clinical quality measures, with an emphasis on electronic clinical quality measures, or eCQMs. Currently at HSAG, she leads a multidisciplinary team investigating the impact of quality measures in CMS reporting programs and developing the triennial Impact Assessment Report. She is the team’s key liaison with CMS and directs project management, research, and analytic activities, including acquisition of large, complex datasets; analytic methodology; data analysis; and reporting. For the past four years, she led a team responsible for the CMS Quality Measure Development Plan (MDP) project, which is mandated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). She also has served as an eCQM subject matter expert for the Hospital Inpatient Value, Incentives, and Quality Reporting (VIQR) Outreach and Education Support Contract. Ms. Hanley has served on national committees examining methodological issues related to eCQMs. She participates in many of the national consensus-based initiatives to maintain and evolve the technology standards used in eCQMs and has a thorough understanding of quality improvement and measure specification methodologies. Prior to joining HSAG, Ms. Hanley was Director, Measure Specification Operations, for the PCPI® (formerly the AMA-convened Physician Consortium for Performance Improvement), where she managed the team responsible for all aspects of specification development and maintenance for quality measures developed by the PCPI, including their use in federal quality reporting programs such as the Physician Quality Reporting System and the CMS Electronic Health Record Incentive Program for Eligible Professionals. Previously Ms. Hanley managed the submission of inpatient quality measure data for three acute care facilities in the Chicago area. Ms. Hanley has a Master of Science degree in Health Systems Management from Rush University in Chicago, IL.
Chiao Wen Lan, PhD, MPH
Dr. Lan is a research scientist with more than10 years of experience in public health research conducting quantitative and qualitative analysis focusing on health equity in underserved communities. Her work includes processing, analyzing, and interpreting large, complex datasets and optimizing processes to improve health outcomes and reduce health inequities among vulnerable populations. Currently at HSAG, she conducts research and supports clinical, technical, and analytic efforts focused on addressing health inequities and kidney disease for the End Stage Renal Disease National Coordinating Center (ESRD NCC). She is supporting CMS in identifying social determinants of health that affect the ESRD community, developing strategic approaches for the use and analysis of healthcare data, and targeting interventions for underserved ESRD patient populations. She supports the ESRD NCC in investigating innovation solutions to advancing kidney care nationwide. Previously she was an epidemiologist for the Northwest Portland Area Indian Health Board, where she served as the co-investigator for a National Institutes of Health grant and led the epidemiological assessment to examine the impacts of maternal substance misuse and neonatal opioid withdrawal symptom in tribal communities. She also evaluated COVID-19 impacts and supported a Centers for Disease Control and Prevention project to prevent suicide, intimate partner violence, and adverse childhood effects in Indian Country during the pandemic. Dr. Lan has been involved in multiple NIH-funded randomized controlled intervention trials aimed at ameliorating the impacts of substance misuse and HIV/AIDS on patients and families around the world, especially in resource-limited settings. A certified public health professional, she holds a doctorate in Community Health Sciences from the UCLA Fielding School of Public Health and a Master of Public Health from Brown University. She has a Bachelor of Science in Molecular Environmental Biology and a Bachelor of Arts in Comparative Literature from the University of California, Berkeley.
Julia Montague Mackeprang, MPH, PMP
Ms. Mackeprang is a health services researcher with over 11 years of quality measurement experience, including technical and project management support for the development of the Quality Measure Index (QMI), development and reevaluation of facility-based outcome measures, and technical assistance to quality measure developers for the Quality Payment Program under cooperative agreements with CMS. Prior to joining HSAG, Ms. Mackeprang served for nearly eight years as a project manager and project coordinator for CMS quality measure development, reevaluation, and implementation contracts at the Yale-New Haven Hospital Center for Outcomes Research and Evaluation Quality Measurement Group. She has expertise in all aspects of the measure development process, including information gathering; developing business cases; recruiting, selecting, and facilitating technical expert panels (TEPs); coordinating and summarizing public comment; submitting candidate measures to the Measures Under Consideration List; supporting rulemaking; and participating in the National Quality Forum endorsement process. Ms. Mackeprang has a Master of Public Health degree in Epidemiology from Columbia University and is a certified Project Management Professional.
Megan Keenan, MPH
Ms. Keenan has eight years of experience managing and coordinating complex projects that focus on measure development, public reporting of quality data, stakeholder engagement, and evaluating the impact of socioeconomic status on patient outcomes. She currently manages measure development and testing projects to support organizations preparing quality measures for use in registries and CMS programs. She also assists with the development of manuscripts summarizing novel findings from CMS-funded measure development projects for publication in peer-reviewed journals. From 2015 to 2019, she directed the CMS Inpatient Psychiatric Facility Outcome and Process Measure Development and Maintenance Task Order under contract to CMS. The project resulted in the public reporting of three quality measures and development of six new quality measures, three of which were submitted to the National Quality Forum and subsequently endorsed. Prior to joining HSAG, Ms. Keenan provided similar expertise for the development and maintenance of quality measures for acute care facilities as a Project Manager at the Yale Center for Outcomes Research and Evaluation (CORE). She holds a Bachelor of Science degree in Biochemistry from Northeastern University and a Master’s degree in Health Policy and Administration from the Yale School of Public Health.
Allison Peel, DC, MHA, MPH, PMP
Director, Clinical Quality Measures
Dr. Peel brings 20 years of measure development and measure maintenance experience to her role at HSAG. She currently serves as the project lead for the SUPPORT Act Section 2003 Planning and Implementation work added under the Impact Assessment Task Order. This involves performance of an environmental scan and development of a Strategic Plan to support implementation of a new CMS electronic prescribing of controlled substances (EPCS) program. HSAG also will develop and execute a comprehensive Education and Outreach Plan to increase awareness of the new program rules among prescribers of controlled substances. Dr, Peel previously served as the primary point of contact on the MACRA Cooperative Agreement Technical Assistance (CATA) task order, successfully launching CMS’s initial support project for recipient measure developers. In this role, she directed a team of measure experts who identified and tailored support for recipients as they developed a variety of measures, including patient-reported outcome performance measures and electronic clinical quality measures. Dr. Peel directed the measure implementation help desk team for the CMS Physician Quality Reporting System (PQRS) and Electronic Prescribing programs. She has extensive experience with development of educational products related to quality measures, including presentations, frequently asked questions, fact sheets, and guidance documents. She has led clinical analytics teams supporting CMS on physician quality measures since the inception of the national physician-based quality measures program in 2007. Her 15 years of clinical experience began as an owner and chiropractic physician. She developed quality assurance/control programs for clinicians in radiology and radiation safety and oversaw operations for internal medicine, physical therapy, mental health, and chiropractic services. Dr. Peel received a Doctor of Chiropractic degree from Palmer College of Chiropractic, where she also completed a radiology residency. She holds Master’s degrees in Public Health and Healthcare Administration from Des Moines (Iowa) University and is certified as a Project Management Professional. She served two governor-appointed terms on the Radiation Advisory Council to the Ohio Board of Health, focusing on providing expert input on radiation quality and safety rules.
Michelle Pleasant, PhD, MA
Dr. Pleasant has served as a researcher on the Impact Assessment of CMS Quality and Efficiency Measures contract for the past three years. Currently as Associate Director, she leads the CMS Quality Measure Development Plan (MDP) project. In her previous role, she outlined, co-authored, and supported federal clearance of the MDP Annual Report, synthesizing information gathered from federal rules, measure stewards, and collaborations with CMS project and measure leads. In support of the CMS Quality Measure Index (QMI) Project, she led the development of testing plans, testing summaries, and a draft methodology report. Dr. Pleasant has conducted literature reviews and environmental scans to support clinical quality measure development and assessment for both the MDP and QMI projects. She also informed the development of qualitative interview questions to engage and learn from Medicare and Medicaid beneficiaries about their recent healthcare experiences. In her previous research focused on vulnerable populations (including older adults with dementia, residents of nursing homes, and persons taking antipsychotic medications), Dr. Pleasant led the study design, data collection, analysis, and application for IRB approval. She conducted and published multiple studies, including a systematic review and assessment of dementia caregiver training and a qualitative study using content theme analysis methodology. Dr. Pleasant holds a doctorate in Aging Studies and a Master of Arts degree in Gerontology from the University of South Florida. She also has a Bachelor of Arts in Psychology and Religion from Florida State University.
Tsu-Hsuan “Sherry” Yang, PharmD
Clinical Pharmacist Researcher and Program Manager
Dr. Yang provides project management and clinical expertise to HSAG on CMS contracts and serves as an investigator for research projects focusing on medication safety. Currently she is leading a study to develop a risk-prediction model using administrative claims data to assess bleeding risk for patients taking anticoagulants. This research is funded by the Gordon and Betty Moore Foundation. Dr. Yang was the principal investigator for two research projects for the Centers for Disease Control and Prevention, each aimed at developing and validating diagnosis code algorithms for potential use in adverse drug event surveillance and quality improvement initiatives. The first study produced an ICD-10 diagnosis code algorithm for identifying bleeding events associated with outpatient anticoagulant exposure; the second study validated diagnosis codes for identifying hypoglycemic events associated with the use of diabetes agents. As a program manager, she also assists in evaluating research funding opportunities, preparing research proposals, and resource planning. Dr. Yang previously oversaw daily operations of CMS measure development and maintenance projects. As Project Director, she oversaw data analysis, subcontractor activities, technical expert panel deliberations, and measure development and maintenance. She was involved in the maintenance of clinical algorithms and technical specifications for measures. She is a Registered Pharmacist in Florida and North Carolina. She graduated from the University of North Carolina PharmD program and holds a Bachelor of Science degree in Biochemistry from North Carolina State University. She completed a two-year fellowship at the University of Florida College of Pharmacy, focusing on medication therapy management program evaluation and outcome research.